Meet Three Boston Scientific Employees Committed to Protecting People From Stroke

NORTHAMPTON, MA / ACCESSWIRE / December 5, 2023 / Advancing science for life is at the core of all we do at Boston Scientific. Our products treat and prevent a broad range of conditions that can diminish a person's quality of life, including stroke. Affecting more than 12 million people annually, stroke happens when blood flow to the brain is reduced or blocked, and can cause lasting, debilitating symptoms.

Meet three employees across the globe who have found their purpose in innovating and advancing products that help people lower their risk of stroke, whether during a medical procedure or daily life.

A constant reminder of the "why"

For senior research and development engineer Luis Lopez-de-Victoria, protecting patients is the reason he always puts his best foot forward at work. His focus area is the SENTINEL^TM Cerebral Protection System, a device that is used to protect patients against the risk of stroke during transcatheter aortic valve replacement heart (TAVR) procedures, an alternative to open-heart surgery.

"One of the ways a stroke can happen is during a TAVR procedure," says Lopez-de-Victoria. "Embolic debris, such as valve tissue, can break loose and travel to the brain, which can block blood flow." SENTINEL is designed to "catch" this debris before it travels to the brain.

After starting his career in the aerospace industry, Lopez-de-Victoria made the transition to Boston Scientific - and the health care field - almost three years ago and hasn't looked back. "What inspires me most about the company are the people, and the mindset that we all share one common goal: putting the patient first," he says.

Lopez-de-Victoria and his team in Maple Grove, Minnesota, specialize in sustainment engineering, which involves gathering feedback from customers and physicians so the team can continuously adapt SENTINEL to meet evolving unmet needs and help more patients.

Besides his interest in technology, Lopez-de-Victoria has a deeply personal motivator in his role. "My mom had a stroke a few years ago," he says. "Thankfully, it was a minor one and she has since recovered, but it's a constant reminder of the ‘why' behind our work. If I can help prevent one person - one family - from experiencing the effects of stroke, then that's everything."

Seeing the whole picture for stroke prevention

As a production director, Colm Sheils is focused on continuously improving processes and adapting them as the company develops new products.

So handeln Sie das Kursziel

Der Analyst erwartet ein Kursziel von 72,45$, was einem Rückgang von -2,95% zum aktuellen Kurs entspricht. Mit diesen Produkten können Sie die Kurserwartungen des Analysten übertreffen.

 

Morgan Stanley

 

Alle Partner

Übernehmen

Für Ihre Einstellungen haben wir keine weiteren passenden Produkte gefunden.
Bitte verändern Sie Kursziel, Zeitraum oder Emittent.Alternativ können Sie auch unsere Derivate-Suchen verwenden
Knock-Out-Suche | Optionsschein-Suche | Zertifikate-Suche

WerbungDisclaimer